BIBH 1

DRUG2 trials

Sponsors

Boehringer Ingelheim

Conditions

Colorectal NeoplasmsLung Neoplasms

Phase 1

Dose-escalation Study of BIBH 1 in Patients With Non-small Cell Lung Cancer Scheduled for Surgical Resection

TerminatedNCT02199886

Boehringer IngelheimLung Neoplasms

Start: 1998-07-31Updated: 2014-07-25

Phase 2

Intravenous BIBH 1 in Patients With Metastatic Colorectal Cancer

CompletedNCT02198274

Boehringer IngelheimColorectal Neoplasms

Start: 2000-02-29Updated: 2014-07-23